DE122007000073I1 - Melatonin enthaltene Arzneimittel - Google Patents

Melatonin enthaltene Arzneimittel

Info

Publication number
DE122007000073I1
DE122007000073I1 DE200712000073 DE122007000073C DE122007000073I1 DE 122007000073 I1 DE122007000073 I1 DE 122007000073I1 DE 200712000073 DE200712000073 DE 200712000073 DE 122007000073 C DE122007000073 C DE 122007000073C DE 122007000073 I1 DE122007000073 I1 DE 122007000073I1
Authority
DE
Germany
Prior art keywords
melatonin
profile
diluent
coating
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE200712000073
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurim Pharmaceuticals 1991 Ltd
Original Assignee
Neurim Pharmaceuticals 1991 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24802245&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122007000073(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurim Pharmaceuticals 1991 Ltd filed Critical Neurim Pharmaceuticals 1991 Ltd
Publication of DE122007000073I1 publication Critical patent/DE122007000073I1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE200712000073 1991-05-09 1992-04-23 Melatonin enthaltene Arzneimittel Pending DE122007000073I1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69771491A 1991-05-09 1991-05-09

Publications (1)

Publication Number Publication Date
DE122007000073I1 true DE122007000073I1 (de) 2008-01-31

Family

ID=24802245

Family Applications (2)

Application Number Title Priority Date Filing Date
DE200712000073 Pending DE122007000073I1 (de) 1991-05-09 1992-04-23 Melatonin enthaltene Arzneimittel
DE69229490T Expired - Lifetime DE69229490T2 (de) 1991-05-09 1992-04-23 Melatonin enthaltende Arzneimittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69229490T Expired - Lifetime DE69229490T2 (de) 1991-05-09 1992-04-23 Melatonin enthaltende Arzneimittel

Country Status (11)

Country Link
US (2) US5500225A (de)
EP (1) EP0518468B1 (de)
JP (1) JPH072694A (de)
AT (1) ATE181670T1 (de)
DE (2) DE122007000073I1 (de)
DK (1) DK0518468T3 (de)
ES (1) ES2134789T3 (de)
GR (1) GR3031257T3 (de)
HK (1) HK1011932A1 (de)
LU (1) LU91378I2 (de)
NL (1) NL300306I1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
IL105240A (en) 1992-04-07 1999-04-11 Neurim Pharma 1991 The use of melatonin in the preparation of a drug for the treatment of benign prostatic hyperplasia
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
AU7550994A (en) * 1993-07-26 1995-02-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Sustained release oral compositions containing melatonin
FR2718020B1 (fr) * 1994-04-01 1996-05-31 Biotec Centre Sa Composition galénique mucoadhésive hétérofonctionnelle.
DE4443175A1 (de) * 1994-12-05 1996-06-13 Jenapharm Gmbh Neue pulsatile Arzneiform
US6469044B1 (en) * 1995-02-01 2002-10-22 Neurim Pharmaceuticals (1991) Ltd. Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
BR9607169A (pt) * 1995-02-01 1997-11-11 Neurim Pharma 1991 Uso de meletonina e formulação farmacêutica para uso no tratamento de um viciado em drogas múltiplas
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
DE69636474T2 (de) * 1995-06-07 2007-06-14 Pliva-Istrazivanje I Razvoj D.O.O. Verfahren zur inhibition einer neoplastischen krankheit in saeugetieren
US5792748A (en) * 1995-06-07 1998-08-11 The General Hospital Corporation Method for inhibiting neoplastic disease in mammals
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19631084A1 (de) 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
ES2187115T3 (es) * 1999-01-20 2003-05-16 Nutricia Nv Preparado para lactantes.
BR0016918A (pt) 2000-01-05 2004-03-23 Neurim Pharma 1991 Processo e formulação para o tratamento de resistência a anti-hipertensivos e condições relacionadas
US20020119191A1 (en) * 2000-04-24 2002-08-29 Hitoo Nishino Pharmaceutical or food composition for treatment or prevention of brain edema
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
US7365238B2 (en) * 2002-02-19 2008-04-29 The Procter And Gamble Company Absorbent article having a dehydration indicator
KR100501827B1 (ko) * 2002-09-24 2005-07-20 한국화학연구원 다층 코팅법을 이용한 멜라토닌 함유 타게팅 약물 전달 기구
US6703412B1 (en) * 2002-09-27 2004-03-09 Holly A. Rosenthal Method of treating sleeplessness with melatonin on an acute basis
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
US7799817B2 (en) * 2004-02-20 2010-09-21 Lifescape Biosciences Inc Compositions and methods for sleep regulation
WO2008116004A2 (en) 2007-03-19 2008-09-25 Vita Sciences, Llc Transdermal patch and method for delivery of vitamin b12
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
KR101809305B1 (ko) 2011-02-11 2017-12-14 제트엑스 파마 엘엘씨 다중미립자 l-멘톨 제제 및 관련 방법
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention
FR3000896B1 (fr) 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
RS58325B1 (sr) 2013-04-23 2019-03-29 Zx Pharma Llc Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom
EP3206665B1 (de) * 2014-10-13 2020-02-26 Worphmed Srl Anhydrische flüssige melatoninzusammensetzung
CN104546777A (zh) * 2014-12-16 2015-04-29 深圳翰宇药业股份有限公司 美乐托宁缓释组合物的制备方法、美乐托宁缓释片的制备方法
NL2015272B1 (en) * 2015-08-05 2017-05-02 Versailles B V Melatonin formulations and methods for preparation and use.
EP3337462B1 (de) * 2016-10-31 2020-09-30 Neurim Pharmaceuticals Ltd. Melatonin-minitabletten und verfahren zu deren herstellung
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited PHARMACEUTICAL COMPOSITION OF MELATONIN
CN113072479A (zh) * 2021-03-26 2021-07-06 罗田县新普生药业有限公司 一种从褪黑素结晶母液中提取褪黑素的方法
WO2023134856A1 (de) * 2022-01-13 2023-07-20 Paditz Ekkehart Säuglingsnahrung und verfahren zu deren herstellung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5584503A (en) * 1978-12-19 1980-06-25 Teijin Ltd Preparing cellulose ester based selective permeable membrane
CA1151862A (en) * 1980-01-24 1983-08-16 Thomas J. Fogarty Flexible calibrator
US4855325A (en) * 1985-01-16 1989-08-08 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
EP0126630B1 (de) * 1983-05-18 1987-09-16 Monash University Verwendung von Melatonin zur Herstellung eines Arzneimittels
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
WO1988006009A1 (en) * 1987-02-13 1988-08-25 Maurizio Graziosi System for making atoxic the shoe bottoms
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
GB8727099D0 (en) * 1987-11-19 1987-12-23 Cellena Cell Eng A G Compositions containing melantonin/homologues
FR2630005B1 (fr) * 1988-04-14 1991-11-29 Goupil Jean Jacques Nouveau medicament anti-depresseur contenant du 5-methoxypsoralene
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
US5151446A (en) * 1989-09-25 1992-09-29 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
JPH03145419A (ja) * 1989-10-31 1991-06-20 Shiseido Co Ltd 紫外線老化の防御薬剤

Also Published As

Publication number Publication date
US5500225A (en) 1996-03-19
DE69229490T2 (de) 2000-02-17
ATE181670T1 (de) 1999-07-15
JPH072694A (ja) 1995-01-06
DE69229490D1 (de) 1999-08-05
ES2134789T3 (es) 1999-10-16
LU91378I2 (en) 2008-01-23
NL300306I1 (nl) 2008-01-02
DK0518468T3 (da) 2000-01-31
HK1011932A1 (en) 1999-07-23
GR3031257T3 (en) 1999-12-31
EP0518468A1 (de) 1992-12-16
EP0518468B1 (de) 1999-06-30
US5498423A (en) 1996-03-12

Similar Documents

Publication Publication Date Title
DE122007000073I1 (de) Melatonin enthaltene Arzneimittel
DE69431729T2 (de) Bromocryptin enthaltende mittel mit beschleunigter freisetzung
DK0494972T3 (da) Brusedosisform samt fremgangsmåde til administration heraf
PT100973A (pt) Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
NO306377B1 (no) Doseform for avgivelse av et medikament
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
ITMI911299A0 (it) Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
DK515489A (da) Dispergerbar laegemiddelformulering
NO894616D0 (no) Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser.
ES2196167T3 (es) Composicion farmaceutica que contiene propionato de 3-(2,2,2-trimetilhidrazinio) y gamma-butirobetaina para el tratamiento de enfermedades cardiovasculares.
KR890701087A (ko) 부스피론 및 그의 염의 경구 투여용 제제
DZ3208A1 (fr) Comprimes faiblement doses et procédé de préparation.
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
DK0615439T3 (da) Iburprofenholdigt retard-lægemiddel og dets anvendelse
KR930017579A (ko) 신경 보호제
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
IL98199A0 (en) Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
DE505608T1 (de) Alpha-ergocryptine enthaltende pharmazeutische zusammensetzungen mit nervenschuetzender wirkung.
DK493887A (da) Buccal formulering
DK117291D0 (da) Doseringsform til oral indgift af laegemiddelstoffer